WHO SMART Guidelines - HIV
1.0.0 - release
WHO SMART Guidelines - HIV
1.0.0 - release
This page is part of the WHO SMART Guidelines - HIV (v1.0.0: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
| Active as of 2025-07-08 |
{
"resourceType" : "ValueSet",
"id" : "HIV.C.DE17",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablevalueset"🔗 ,
"http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablevalueset"🔗 ,
"http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-computablevalueset"
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet HIV.C.DE17</b></p><a name=\"HIV.C.DE17\"> </a><a name=\"hcHIV.C.DE17\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profiles: <a href=\"http://hl7.org/fhir/uv/crmi/STU1/StructureDefinition-crmi-shareablevalueset.html\">CRMI Shareable ValueSet</a>, <a href=\"http://hl7.org/fhir/uv/crmi/STU1/StructureDefinition-crmi-publishablevalueset.html\">CRMI Publishable ValueSet</a>, <a href=\"http://hl7.org/fhir/uv/crmi/STU1/StructureDefinition-crmi-computablevalueset.html\">CRMI Computable ValueSet</a></p></div><ul><li>Include these codes as defined in <a href=\"CodeSystem-HIVConcepts.html\"><code>http://smart.who.int/hiv/CodeSystem/HIVConcepts</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46C.46DE18\">HIV.C.DE18</a></td><td>TDF + FTC</td><td>Treated with tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) pre-exposure prophylaxis (PrEP) regimen (oral PrEP)</td></tr><tr><td><a href=\"CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46C.46DE19\">HIV.C.DE19</a></td><td>TDF</td><td>Treated with single-agent tenofovir disoproxil fumarate (TDF) pre-exposure prophylaxis (PrEP) regimen (oral PrEP)</td></tr><tr><td><a href=\"CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46C.46DE20\">HIV.C.DE20</a></td><td>TDF + 3TC</td><td>Treated with tenofovir disoproxil fumarate (TDF) and lamivudine (3TC) pre-exposure prophylaxis (PrEP) regimen (oral PrEP)</td></tr><tr><td><a href=\"CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46C.46DE21\">HIV.C.DE21</a></td><td>Other TDF-based regimen</td><td>Treated with other tenofovir disoproxil fumarate (TDF)-based regimen (oral PrEP)</td></tr><tr><td><a href=\"CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46C.46DE22\">HIV.C.DE22</a></td><td>Dapivirine vaginal ring (DVR)</td><td>Dapivirine vaginal ring (DVR) for HIV prevention</td></tr><tr><td><a href=\"CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46C.46DE23\">HIV.C.DE23</a></td><td>CAB-LA</td><td>Long-acting injectable cabotegravir</td></tr></table></li></ul></div>"
},
"url" : "http://smart.who.int/hiv/ValueSet/HIV.C.DE17",
"version" : "1.0.0",
"name" : "HIVCDE17",
"title" : "Current PrEP regimen ValueSet",
"status" : "active",
"experimental" : true,
"date" : "2025-07-08T23:21:58+02:00",
"publisher" : "WHO",
"contact" : [
{
"name" : "WHO",
"telecom" : [
{
"system" : "url",
"value" : "http://who.int"
}
]
}
],
"description" : "Value set of HIV pre-exposure prophylaxis (PrEP) regimen",
"compose" : {
"include" : [
{
"system" : "http://smart.who.int/hiv/CodeSystem/HIVConcepts",
"concept" : [
{
"code" : "HIV.C.DE18",
"display" : "TDF + FTC"
},
{
"code" : "HIV.C.DE19",
"display" : "TDF"
},
{
"code" : "HIV.C.DE20",
"display" : "TDF + 3TC"
},
{
"code" : "HIV.C.DE21",
"display" : "Other TDF-based regimen"
},
{
"code" : "HIV.C.DE22",
"display" : "Dapivirine vaginal ring (DVR)"
},
{
"code" : "HIV.C.DE23",
"display" : "CAB-LA"
}
]
}
]
}
}